Oral lipid nanoparticle drug shows promise for preventing colitis-associated cancer in mice : vimarsana.com

An oral lipid nanoparticle drug prevents tumor development in mice, suggesting this is a promising drug formulation for preventing colitis-associated cancer, according to a study led by researchers in the Institute for Biomedical Sciences at Georgia State University.

Related Keywords

Georgia , United States , Atlanta , Zahra Alghoul , Chunhua Yang , Danielle Ellis , Didier Merlin , Crohn Colitis Foundation , Department Of Chemistry At Georgia , Institute For Biomedical Sciences , National Institute Of Diabetes , Atlanta Veterans Affairs Medical Center , Department Of Veterans Affairs , Institute For Biomedical Sciences At Georgia , Biomedical Sciences , Georgia State , Regent Professor , Atlanta Veterans Affairs Medical , Dingpei Long , Colitis Foundation , Junsik Sung , National Institute , Kidney Diseases , National Institutes , Cancer , Anoparticle , Hronic , Olon , Ompound , Crohn 39s Disease , Na , Dna Damage , Rugs , Fficacy , Nflammation , Nflammatory Bowel Disease , Anoparticles , Esearch , Umor , Lcerative Colitis , Eterans Affairs ,